I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Bitzenhofer, Michaela
9
results:
Search for persons
X
Format
Online (9)
Mediatypes
Articles (Online) (3)
OpenAccess-fulltext (6)
Languages
german (1)
english (7)
Sorted by: Relevance
Sorted by: Year
?
1
Real-World Use, Safety, and Patient Experience of 20% Subcu..:
Fasshauer, Maria
;
Borte, Michael
;
Bitzenhofer, Michaela
...
Advances in Therapy. 40 (2023) 12 - p. 5168-5187 , 2023
Link:
https://doi.org/10.1007/..
?
2
Humoral response to mRNA vaccines against SARS-CoV-2 in pat..:
Bitzenhofer, Michaela
;
Suter-Riniker, Franziska
;
Moor, Matthias B.
...
PLOS ONE. 17 (2022) 6 - p. e0268780 , 2022
Link:
https://doi.org/10.1371/..
?
3
Real-World Use, Safety, and Patient Experience of 20% Subcu..:
Fasshauer, Maria
;
Borte, Michael
;
Bitzenhofer, Michaela
...
https://boris.unibe.ch/186629/. , 2023
Link:
https://boris.unibe.ch/1..
?
4
Real-World Use, Safety, and Patient Experience of 20% Subcu..:
Fasshauer, Maria
;
Borte, Michael
;
Bitzenhofer, Michaela
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611600/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
5
Real-world utilization, safety and patient experience of 20..:
Fasshauer, Maria
;
Borte, Michael
;
Bitzenhofer, Michaela
...
https://boris.unibe.ch/175541/. , 2022
Link:
https://boris.unibe.ch/1..
?
6
Humoral response to mRNA vaccines against SARS-CoV-2 in pat..:
Bitzenhofer, Michaela
;
Suter-Riniker, Franziska
;
Moor, Matthias B
...
https://boris.unibe.ch/170560/. , 2022
Link:
https://boris.unibe.ch/1..
?
7
Antikörpermangelsyndrome: Epidemiologie, klinische Manifest..:
Jandus, Peter
;
Bitzenhofer-Grüber, Michaela
Therapeutische Umschau. 79 (2022) 6 - p. 279-283 , 2022
Link:
https://doi.org/10.1024/..
?
8
Real-World Use, Safety, and Patient Experience of 20% Subcu..:
Adis journalson behalf of
;
Maria Fasshauer
;
Michael Borte
...
doi:10.6084/m9.figshare.23932341.v2. , 2023
Link:
https://doi.org/10.6084/..
?
9
Humoral response to mRNA vaccines against SARS-CoV-2 in pat..:
Michaela Bitzenhofer
;
Franziska Suter-Riniker
;
Matthias B Moor
...
https://doi.org/10.1371/journal.pone.0268780. , 2022
Link:
https://doi.org/10.1371/..
1-9